Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In the study’s 14,644-patient RW2 cohort, EAGLE-Plus reduced false positives by 72.7% while maintaining comparable sensitivity. | QUANTITATIVE | Supported | 0.8808 | 1 of 4 | 143 |
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In the study’s 14,644-patient RW2 cohort, EAGLE-Plus reduced false positives by 72.7% while maintaining comparable sensitivity. | QUANTITATIVE | Supported | 0.8808 | 1 of 4 | 143 |